Aude G Chapuis

14PUBLICATIONS
99CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 09, 2026
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.

|Apr 27, 2026
Safety and Clinical Outcomes of Pooled Donor, Nonengrafting Expanded Progenitor Cells in Single-Unit Cord Blood Transplantation.

|Feb 04, 2026
Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics.

Thomas M Schmitt, Kelsey Furiya, Cheryl Black

|Jan 03, 2026
A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands.

Shihong Zhang, Tzu-Hao Tang, Sinéad Kinsella

|Jun 05, 2025
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.

Francesco Mazziotta, Lauren E Martin, Daniel N Egan

|Sep 30, 2024
Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activity.

Jihoon William Lee, Emily Y Chen, Taylor Hu

Pageof 3

Frequent Collaborators

5 joint publications

Thomas M Schmitt

5 joint publications

Cecilia Yeung

4 joint publications

Cameron J Turtle

4 joint publications

Valentin Voillet